Literature DB >> 23553344

Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects.

Karen M Rodrigue1, Jennifer R Rieck, Kristen M Kennedy, Michael D Devous, Ramon Diaz-Arrastia, Denise C Park.   

Abstract

IMPORTANCE: Identifying risk factors for increased β-amyloid (Aβ) deposition is important for targeting individuals most at risk for developing Alzheimer disease and informing clinical practice concerning prevention and early detection.
OBJECTIVE: To investigate risk factors for Aβ deposition in cognitively healthy middle-aged and older adults. Specifically, we hypothesized that individuals with a vascular risk factor such as hypertension, in combination with a genetic risk factor for Alzheimer disease (apolipoprotein E ε4 allele), would show greater amyloid burden than those without such risk.
DESIGN: Cross-sectional study.
SETTING: General community. PARTICIPANTS: One hundred eighteen well-screened and cognitively normal adults, aged 47 to 89 years. Participants were classified in the hypertension group if they reported a medical diagnosis of hypertension or if blood pressure exceeded 140 mm Hg systolic/90 mm Hg diastolic, as measured across 7 occasions at the time of study. INTERVENTION: Participants underwent Aβ positron emission tomography imaging with radiotracer fluorine 18-labeled florbetapir. Participants were genotyped for apolipoprotein E and were classified as ε4(+) or ε4(-). MAIN OUTCOME MEASURE: Amyloid burden.
RESULTS: Participants in the hypertension group with at least 1 ε4 allele showed significantly greater amyloid burden than those with only 1 risk factor or no risk factors. Furthermore, increased pulse pressure was strongly associated with increased mean cortical amyloid level for subjects with at least 1 ε4 allele. CONCLUSIONS AND RELEVANCE: Vascular disease is a prevalent age-related condition that is highly responsive to both behavioral modification and medical treatment. Proper control and prevention of risk factors such as hypertension earlier in the life span may be one potential mechanism to ameliorate or delay neuropathological brain changes with aging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553344      PMCID: PMC3968915          DOI: 10.1001/jamaneurol.2013.1342

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  40 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Differential effects of age and history of hypertension on regional brain volumes and iron.

Authors:  Karen M Rodrigue; E Mark Haacke; Naftali Raz
Journal:  Neuroimage       Date:  2010-10-20       Impact factor: 6.556

3.  [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.

Authors:  M A Mintun; G N Larossa; Y I Sheline; C S Dence; S Y Lee; R H Mach; W E Klunk; C A Mathis; S T DeKosky; J C Morris
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

4.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

5.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

6.  Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; James D Acker
Journal:  Neuropsychology       Date:  2007-03       Impact factor: 3.295

7.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

8.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

9.  Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly.

Authors:  Mary N Haan; Elizabeth R Mayeda
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-07-16

10.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

Authors:  Keith D Coon; Amanda J Myers; David W Craig; Jennifer A Webster; John V Pearson; Diane Hu Lince; Victoria L Zismann; Thomas G Beach; Doris Leung; Leslie Bryden; Rebecca F Halperin; Lauren Marlowe; Mona Kaleem; Douglas G Walker; Rivka Ravid; Christopher B Heward; Joseph Rogers; Andreas Papassotiropoulos; Eric M Reiman; John Hardy; Dietrich A Stephan
Journal:  J Clin Psychiatry       Date:  2007-04       Impact factor: 4.384

View more
  99 in total

1.  Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.

Authors:  Daniel A Nation; Jean Ho; Belinda Yew
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 2.  Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain Function.

Authors:  Gérard N Bischof; Denise C Park
Journal:  Psychosom Med       Date:  2015 Jul-Aug       Impact factor: 4.312

3.  ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriers.

Authors:  G Peggy McFall; Sandra A Wiebe; David Vergote; David Westaway; Jack Jhamandas; Lars Bäckman; Roger A Dixon
Journal:  Neuropsychology       Date:  2014-12-01       Impact factor: 3.295

Review 4.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

5.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.

Authors:  Sylvia Villeneuve; William J Jagust
Journal:  J Prev Alzheimers Dis       Date:  2015-03

Review 6.  Cell death assays for neurodegenerative disease drug discovery.

Authors:  Jeremy W Linsley; Terry Reisine; Steven Finkbeiner
Journal:  Expert Opin Drug Discov       Date:  2019-06-10       Impact factor: 6.098

Review 7.  Preventing dementia by preventing stroke: The Berlin Manifesto.

Authors:  Vladimir Hachinski; Karl Einhäupl; Detlev Ganten; Suvarna Alladi; Carol Brayne; Blossom C M Stephan; Melanie D Sweeney; Berislav Zlokovic; Yasser Iturria-Medina; Costantino Iadecola; Nozomi Nishimura; Chris B Schaffer; Shawn N Whitehead; Sandra E Black; Leif Østergaard; Joanna Wardlaw; Steven Greenberg; Leif Friberg; Bo Norrving; Brian Rowe; Yves Joanette; Werner Hacke; Lewis Kuller; Martin Dichgans; Matthias Endres; Zaven S Khachaturian
Journal:  Alzheimers Dement       Date:  2019-07       Impact factor: 21.566

8.  Hypertension and dementia.

Authors:  Costantino Iadecola
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

9.  Contribution of cerebrovascular health to the diagnosis of Alzheimer disease.

Authors:  Karen M Rodrigue
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

10.  Disrupted white matter structure underlies cognitive deficit in hypertensive patients.

Authors:  Xin Li; Chao Ma; Xuan Sun; Junying Zhang; Yaojing Chen; Kewei Chen; Zhanjun Zhang
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.